Download App

Log in to access Online Inquiry
Company Overview More
China Pioneer Pharmaceutical Holdings Co., Ltd. is an investment holding company mainly engaged in comprehensive marketing, promotion and channel management services of pharmaceutical products and medical devices. The company operates through two business divisions. Ophthalmic Pharmaceutical products Division sells ophthalmic pharmaceutical products through the provision of channel management services and joint promotion services. The product segment, which provides integrated marketing, promotion and channel management services, mainly sells all pharmaceutical products and medical devices except ophthalmic pharmaceutical products. The company is also engaged in the manufacturing of chemical and pharmaceutical products through its subsidiaries.
CEO: Xinzhou Li
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

01345 PIONEER PHARM
2.460-0.020-0.81%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30
Assets
Current assets
Inventory
-34.27% 294.95M -35.09% 217.14M 14.08% 448.73M 4.11% 334.52M
Accounts receivable
-16.71% 306.26M -11.44% 308.8M 12.32% 367.69M 5.69% 348.68M
Related party payments receivable
-99.83% 75K -76.78% 14.1M 391.53% 43.07M 4.69% 60.74M
Advance deposits and other receivables
-- -- -- -- -58.67% 3.32M -85.27% 4.34M
Withholding and tax receivable
94.95% 3.21M -- -- -76.85% 1.64M 1113.99% 4.16M
Cash and equivalents
95.51% 224.85M -1.9% 162.55M -57.45% 115.01M 65.2% 165.7M
Secured deposit
-18.58% 6.57M -96.76% 340K -35.36% 8.07M 14.26% 10.48M
Financial assets at fair value-current assets
26.96% 177.23M 455.96% 130M -29.69% 139.6M -88.46% 23.38M
Special items of current assets
-- -- -- -- -- -- -- 816K
Total current assets
-10.11% 1.01B -12.58% 832.92M -8.67% 1.13B -9.36% 952.81M
Non-current assets
Property, plant and equipment
13.96% 83.71M 51.94% 84.96M 54.77% 73.45M 22.65% 55.92M
Advance payment
2.64% 16.59M -- -- -- 16.16M -- --
Long-term receivables
-- -- -- -- -- -- -77.58% 857K
Associated company interest
147.05% 89.47M 71.68% 103.25M 47.6% 36.21M -0.46% 60.14M
Intangible assets
-2.36% 45.92M 571.92% 46.02M 292.58% 47.03M -49.1% 6.85M
Deferred tax assets
-38.75% 11.96M 8.62% 12.74M 150.69% 19.52M 12.16% 11.73M
Special items of non-current assets
-37.85% 67.69M -45.65% 84.79M -51.24% 108.92M -28.78% 155.99M
Total non-current assets
4.66% 315.34M 13.82% 331.76M -4.8% 301.3M -17.37% 291.48M
Total assets
-7% 1.33B -6.4% 1.16B -7.88% 1.43B -11.37% 1.24B
Liabilities
Current liabilities
Accounts payable
-30.98% 297.05M -33.73% 102.78M 39.87% 430.36M -16.62% 155.1M
Tax payable
-18.46% 24.61M -49.6% 14.59M 0.74% 30.18M 120.4% 28.94M
Dividend payable
-- -- -- -- -- -- -- 38.71M
Amounts payable to associated parties-current liabilities
-- 2.03M -- -- -- -- -- 1.7M
Bank loans and overdrafts
-8.15% 13.87M 100.71% 89.07M -69.09% 15.1M -29.11% 44.38M
Financial lease liabilities-current liabilities
1514.29% 113K -- -- -94.07% 7K -95.43% 121K
Special items of current liabilities
19.35% 10.52M -27.46% 8.92M -18.48% 8.82M 46.59% 12.3M
Total current liabilities
-28.13% 348.2M -23.43% 215.36M 21.38% 484.46M 2.39% 281.25M
Net current assets
3.47% 664.95M -8.04% 617.57M -23.03% 642.68M -13.51% 671.57M
Total assets less current liabilities
3.85% 980.28M -1.43% 949.33M -18.02% 943.98M -14.72% 963.05M
Non-current liabilities
Financial lease liabilities-non-current liabilities
-- 71K -- -- -- -- -- 9K
Deferred tax liability
99.37% 25.63M 60.66% 12.85M 73.69% 12.85M -- 8M
Deferred income-non-current liabilities
124.61% 43.6M -- 19.41M -- 19.41M -- --
Total non-current liabilities
114.78% 69.3M 302.85% 32.26M 331.97% 32.26M 340.78% 8.01M
Total liabilities
-19.2% 417.49M -14.39% 247.62M 27.09% 516.73M 4.62% 289.25M
Total assets less total liabilities
-0.08% 910.99M -3.98% 917.06M -20.3% 911.72M -15.29% 955.04M
Total equity and non-current liabilities
3.85% 980.28M -1.43% 949.33M -18.02% 943.98M -14.72% 963.05M
Equity
Share capital
0% 77.57M 0% 77.57M 0% 77.57M -0.25% 77.57M
Reserve
-0.18% 830.4M -4.57% 835.41M -21.82% 831.87M -16.66% 875.45M
Legal reserve
-0.18% 830.4M -4.57% 835.41M -21.82% 831.87M -16.66% 875.45M
Shareholders' Equity
-0.16% 907.97M -4.2% 912.98M -20.33% 909.43M -15.53% 953.02M
Non-controlling interest
32.22% 3.02M 101.68% 4.08M -6.48% 2.28M 365.4% 2.03M
Total equity
-0.08% 910.99M -3.98% 917.06M -20.3% 911.72M -15.29% 955.04M
Total equity and total liabilities
-7% 1.33B -6.4% 1.16B -7.88% 1.43B -11.37% 1.24B
Currency Unit
CNYCNYCNYCNY
Accounting Standards
IASIASIASIAS
Audit Opinions
Unqualified Opinion--Unqualified Opinion--
Auditor
Deloitte Guan Huang Chen Fang Accountants--Deloitte Guan Huang Chen Fang Accountants--

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%